A

biotech and financial markets

[Frank S. David @Frank_S_David]

Great example below of how to analyze a Phase 3 trial.

Follows guidance in 2 of my fave papers, Pocock & Stone's guides to evaluating (+) and (-) studies -- must-reads for biotech folks imho.

1. https://t.co/lO0jsLUVK1
2. https://t.co/Qx4Fy5Xh4x

HT @AppleHelix @Prof_Oak_

[A @MasterSushiPo]

$TRVI with estimated 6B peak sales for Haduvio across all three indications is currently trading at 2.5B marketcap. With modest 2x premium and 12B target could mean 5x from here. Good data also.

[A @MasterSushiPo]

$XENE neurology pipeline and class dominance looks like a very attractive asset to big pharma. Trading at 67 bucks atm.

[A @MasterSushiPo]

@Dakshdesigns https://t.co/OaL5L5F8WY

[A @MasterSushiPo]

@jasmyintl @rasmusjuhanson @KiisaGertrud @SooAndry

[A @MasterSushiPo]

@voxel__bunny @JaduHologram @rasmusjuhanson @KiisaGertrud

[Forbes @Forbes]

It has finally happened. The Harry Potter flagship store opened in NYC https://t.co/kFqCsCRRYS

[A @MasterSushiPo]

@latokens #Latoken #ShibOnLatoken

[Vincent Chan @vincentchanco]

No one knows when the stock market bubble will pop. It could pop today, tomorrow or in the next 5 years. If the latter, you would’ve missed out on years of new all time highs. Time in the market beats timing the market.

[Vincent Chan @vincentchanco]

Happy Lunar New Year!! 🧧🐲

[A @MasterSushiPo]

Thank you @chrisklafford for spending 228 minutes with me this year on @Spotify. You are my #1. #2020Wrapped https://t.co/GsVk8kReUr

[A @MasterSushiPo]

"Life can only be understood backwards;
but it must be lived forwards.”
Soren Kierkegaard